Management of the Newborn When Maternal TB Suspected

Slides:



Advertisements
Similar presentations
ISTC Training Modules 2008 Your name Institution/organization Meeting Date.
Advertisements

Your name Institution/organization Meeting Date. Introduction.
Discussion group 1 TB preventive therapy for PLWHA Alasdair Reid for Fabio Scano THD unit Stop TB department WHO.
Nodules and infiltrates
June 2004 HITCH Training Slide Set #3 Special Considerations in Antiretroviral Therapy.
TB in Tennessee The Good, the Bad, and the Ugly Jason Cummins, MPH April 30, 2014.
Tuberculosis in Children: Prevention Module 10C - March 2010.
Continuity Clinic Tuberculosis. Continuity Clinic Objectives Know current epidemiologic trends in TB Know indications for testing for TB exposure and.
TB Contact Investigation
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
World Health Organization TB Case Definitions
Introduction to Tuberculosis
Why do we test? 1.We want to prevent an outbreak of Tuberculosis in our campus community 2.We want to find those that are affected and get them treated.
Diagnosis of TB.
Tuberculosis (TB) PHCL 442 Lab Discussion Jamilah Al-Saidan, M.Sc.
Unit 5: IPT Isoniazid TB Preventive Therapy
TUBERCULOSIS Diagnosis & treatment
Xpert in the diagnostic algorithm of pulmonary TB in adult patients who are neither high risk for HIV, nor high risk for MDR-TB Preparations for the global.
Current international guidelines recommend 6–9 months of isoniazid (INH) preventive chemotherapy to prevent the development of active tuberculosis in.
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
“Don’t tell me TB is under control!” Understanding TB
Tuberculosis in Pregnancy Max Brinsmead MB BS PhD May 2015.
Rangel PDSA TB Didactic TB or not TB?. AIM Statement In order to improve care at the Charles Rangel Clinic, we will implement a tuberculosis screening.
Tuberculosis Research of INA-RESPOND on Drug-resistant
TB Control Program County of San Diego Challenges: Cross border Continuity of TB Care Response:CureTBUS/Mexico Tuberculosis Referral and Information Program.
TB 101 Part II Brenda Mayes, R. N. March TREATMENT TB DISEASE MDR XDR LATENT TB INFECTION.
Treatment of Tuberculosis: New Case Case Studies Module 7A2 – March 2010.
V IRGINIA C OHORT D ATA – 5 YEAR TRENDS AFTER 4 YEARS OF LOCAL COHORT REVIEW Virginia achievement on National TB Indicators for the past 5 years – where.
Increased case detection in infants and children Robert Gie Childhood TB Subgroup.
Preparing for Cohort Review & Standard Forms for Cohort Presentation June 16, 2010 Kieran Hartsough.
HIV/TB – Case Studies David Schlossberg, MD, FACP Medical Director, TB Control Program Philadelphia Department of Health.
Module 2 TB Disease Transmission & Prevention. Pulmonary Tuberculosis Extra -Pulmonary TB an infectious disease caused by a microorganism called Mycobacterium.
Kaiser Oakland Contact Investigation CTCA Conference May 6 th, 2010 Tara Greenhow, MD Pediatric Infectious Diseases Kaiser Permanente San Francisco.
Unit 5 Isoniazid Prevention Therapy: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Tuberculosis August 17, 2010 Tuberculosis Mycobacterium tuberculosis – Fastidious, aerobic, acid-fast bacillus Tremendous increase in incidence over.
Unit 11 Drug Resistance and MDR-TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Pulmonary TB aspects Etienne Leroy Terquem – Pierre L’Her SPI / ISP Soutien Pneumologique International / International Support for Pulmonology Nodule.
TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.
Tuberculosis in Children and Young Adults
LEARNING MODULE TITLE SUBTITLE. HISTORY OF PRESENT ILLNESS An 18 year-old woman with no past medical history and no known risks for TB presents with several.
TB IN CHILDREN & PREGNANT WOMEN
Roundtable. Detection and treatment of TB Andrew Black.
Case Discussion 2 - TB IN CHILDREN by Dr. Jeyaseelan P. Nachiappan & Dr. Suryati Adnan 1 Picture of CPG Cover.
CHILDREN and HIV.
Tuberculosis (TB) PHCL 442 Lab Discussion 4 Raniah Al-Jaizani M.Sc.
BCG VACCINATION.
Whole-Genome Sequencing; It’s Not Just For Epis
Tuberculosis for Addiction Counselors
Guidance on completion of Isoniazid Preventive Therapy register
TUBERCULOSIS IN JAPAN ANNUAL REPORT – 2016.
Infant born with mother Tuberculosis
This is an archived document.
Maternal Toxicity Management
Treatment of Latent TB Infection (LTBI)
Maternal Toxicity Management
Protocol References Section Title 6.2 Entry Visit 5.1
This is an archived document.
Nucleic Acid Amplification Test for Tuberculosis
Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors 
Presentation 10 Analysing results and defining cases
بسم الله الرحمن الرحيم.
Diagnosed Food Handlers
Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors 
Tb: Screening & Diagnosis (1)
Goal Objectives Expected Outcomes
Anthony D Harries Ministry of Health, Malawi
Tuberculosis Control Program
Interview Timeframes Conduct a minimum of 2 interviews: 1st interview
5th edition NTP MANUAL OF PROCEDURES Case Finding
Procedures (Decision on Diagnosis based on Laboratory Results)
Presentation transcript:

Management of the Newborn When Maternal TB Suspected Maternal positive TB skin test or suspected pulmonary TB during pregnancy Management of the Newborn When Maternal TB Suspected Abnormal Maternal CXR Maternal CXR Normal Maternal CXR Is mother contagious? Mother is contagious if: Maternal CXR with infiltrates or cavitation (active TB disease) and/or Recent AFB sputum smear or culture positive for TB Mother is NOT contagious if: No symptoms AND CXR shows inactive or healed disease (i.e. calcified granuloma or healed scars) Previously diagnosed, on TB treatment for at least 2 weeks AND Mother’s sputum AFB smears and TB cultures are negative x 3 specimens Mother is NOT contagious No separation of mother from infant indicated May breastfeed No TB treatment or evaluation of infant indicated NO YES Ask if household contacts have TB or symptoms of TB Evaluation and treatment for TB exposed infants: Consider pediatric TB specialist consult Obtain infant CXR and clinical assessment to rule out TB disease, if negative start INH prophylaxis If infant CXR or clinical assessment are suspicious for TB disease, consult pediatric TB or ID specialist for further evaluation and treatment Separation from mother is NOT required if no drug resistance and mother adheres to treatment Refer symptomatic adult contacts for TB test Refer adults with positive skin tests for CXR Follow up of infant: Refer infant to TB clinic for follow up Continue INH prophylaxis for 3-6 months depending on exposure TB skin test for infant at 3-6 months If infant’s skin test negative (<5mm) and no TB exposure for 3 months, may stop INH prophylaxis If infant’s skin test positive (> 5mm), complete 9 months INH If adult CXR concerning for active TB disease Either keep infant separate from adult TB case or start infant on INH prophylaxis